Pharmacology Watch – May 1, 2017
May 1, 2017
View Issues
-
Study Shows Risks of Discontinuing Therapy in Venous Thromboembolism Patients
Patients with venous thromboembolism, which includes deep vein thrombosis and pulmonary embolism, are at risk for recurrence after discontinuing therapy, even if the event was unprovoked.
-
Sciatica Drug Demonstrates Little Efficacy
The authors of a recent study concluded that treatment with pregabalin did not reduce the intensity of leg pain associated with sciatica significantly nor did it improve other outcomes significantly.
-
Vitamin D and Cancer Rates in Postmenopausal Women
Investigators determined vitamin D plus calcium did not reduce cancer rates significantly, but more research is needed.
-
FDA Actions
In this section: The agency approves exciting new treatment for multiple sclerosis, green lights an injection for atopic dermatitis, gives the go ahead to an add-on treatment for Parkinson's disease, and signs off on a drug for Duchenne muscular dystrophy.